The UK10K project identifies rare variants in health and disease

Writing group(Wellcome Sanger Institute), Klaudia Walter(Wellcome Sanger Institute), Josine L. Min(Wellcome Sanger Institute), Jie Huang(Wellcome Sanger Institute), Lucy Crooks(Wellcome Sanger Institute), Yasin Memari(Wellcome Sanger Institute), Shane McCarthy(King's College London), John R. B. Perry(King's College London), Changjiang Xu(Jewish General Hospital), Marta Futema(University of Bristol), Daniel Lawson(European Bioinformatics Institute), Valentina Iotchkova(European Bioinformatics Institute), Stephan Schiffels(Wellcome Sanger Institute), Audrey E. Hendricks(Wellcome Sanger Institute), Petr Danecek(Jewish General Hospital), Rui Li(Queen Mary University of London), James S. Floyd(University of Leicester), Louise V. Wain(University of Leicester), Inês Barroso(University of Cambridge), Steve E. Humphries(Wellcome Sanger Institute), Matthew E. Hurles(Wellcome Sanger Institute), Eleftheria Zeggini(Wellcome Sanger Institute), Jeffrey C. Barrett(Wellcome Sanger Institute), Vincent Plagnol(King's College London), J. Brent Richards(King's College London), Celia M. T. Greenwood(Jewish General Hospital), Nicholas J. Timpson(Wellcome Sanger Institute), Richard Durbin(University of Cambridge), Nicole Soranzo(University of Cambridge), Production group(Wellcome Sanger Institute), Senduran Bala(Wellcome Sanger Institute), Peter Clapham(Wellcome Sanger Institute), Guy Coates(Wellcome Sanger Institute), Tony Cox(Wellcome Sanger Institute), Allan Daly(BGI Group (China)), Petr Danecek(Wellcome Sanger Institute), Yuanping Du(BGI Group (China)), Richard Durbin(Wellcome Sanger Institute), Sarah Edkins(European Bioinformatics Institute), Peter Ellis(BGI Group (China)), Paul Flicek(BGI Group (China)), Xiaosen Guo(BGI Group (China)), Xueqin Guo(BGI Group (China)), Liren Huang(BGI Group (China)), David K. Jackson(Wellcome Sanger Institute), Christopher Joyce(Wellcome Sanger Institute), Thomas Keane(Wellcome Sanger Institute), Anja Kolb-Kokocinski(BGI Group (China)), Cordelia Langford(BGI Group (China)), Rui Li(BGI Group (China)), Jieqin Liang(BGI Group (China)), Hong Lin(BGI Group (China)), Ryan Liu(Wellcome Sanger Institute), John Maslen(Wellcome Sanger Institute), Shane McCarthy(Wellcome Sanger Institute), Dawn Muddyman(Wellcome Sanger Institute), Michael A. Quail(Jewish General Hospital), Jim Stalker(BGI Group (China)), Jianping Sun(BGI Group (China)), Jing Tian(BGI Group (China)), Guangbiao Wang(BGI Group (China)), Jun Wang(BGI Group (China)), Yu Wang(BGI Group (China)), Kim Wong(University of Cambridge), Pingbo Zhang(BGI Group (China)), Cohorts group(Great Ormond Street Hospital for Children NHS Foundation Trust), Inês Barroso(University of Cambridge), Ewan Birney(European Bioinformatics Institute), Chris Boustred(University of Trieste), Lu Chen(University of Cambridge), Gail Clement(King's College London), Massimiliano Cocca(University of Trieste), Petr Danecek(Wellcome Sanger Institute), George Davey Smith(Wellcome Sanger Institute), Ian N.M. Day(European Bioinformatics Institute), Aaron Day-Williams(Biogen (United States)), Thomas A. Down(Guy's Hospital), Ian Dunham(European Bioinformatics Institute), Richard Durbin(Wellcome Sanger Institute), David M. Evans(Translational Research Institute), Tom R. Gaunt(King's College London), Matthias Geihs(Wellcome Sanger Institute), Celia M. T. Greenwood(Jewish General Hospital), Deborah Hart(King's College London), Audrey E. Hendricks(Wellcome Sanger Institute), Bryan Howie(King's College London), Jie Huang(European Bioinformatics Institute), Tim Hubbard(Guy's Hospital), Pirro G. Hysi(King's College London), Valentina Iotchkova(European Bioinformatics Institute), Yalda Jamshidi(St George's, University of London), Konrad J. Karczewski(Broad Institute), John P. Kemp(Translational Research Institute), Geneviève Lachance(King's College London), Daniel Lawson(Broad Institute), Monkol Lek(Centre for Human Genetics), Margarida Lopes(Centre for Human Genetics), Daniel G. MacArthur(Broad Institute), Jonathan Marchini(Centre for Human Genetics), Massimo Mangino(King's College London), Iain Mathieson(Harvard University), Shane McCarthy(Wellcome Sanger Institute), Yasin Memari(King's College London), Sarah Metrustry(King's College London), Josine L. Min(University of Bristol), Alireza Moayyeri(King's College London), Dawn Muddyman(Wellcome Sanger Institute), Kate Northstone(University of Cambridge), Kalliope Panoutsopoulou(King's College London), Lavinia Paternoster(King's College London), John R. B. Perry(King's College London), Lydia Quaye(European Bioinformatics Institute), J. Brent Richards(King's College London), Susan Ring(University of Bristol), Graham R. S. Ritchie(European Bioinformatics Institute), Stephan Schiffels(King's College London), Hashem A. Shihab(University of Leicester), So–Youn Shin(University of Cambridge), Kerrin S. Small(Centre for Human Genetics), María Soler Artigas(University of Leicester), Nicole Soranzo(University of Cambridge), Lorraine Southam(Centre for Human Genetics), Timothy D. Spector(King's College London), Beaté St Pourcain(University Of Bristol Dental Hospital), Gabriela Surdulescu(University of Leicester), Ioanna Tachmazidou(King's College London), Nicholas J. Timpson(Translational Research Institute), Martin D. Tobin(University of Leicester), Ana M. Valdes(King's College London), Peter M. Visscher(Translational Research Institute), Louise V. Wain(University of Leicester), Klaudia Walter(Wellcome Sanger Institute), Kirsten Ward(Translational Research Institute), Scott G. Wilson(The University of Western Australia), Kim Wong(King's College London), Jian Yang(Translational Research Institute), Eleftheria Zeggini(Wellcome Sanger Institute), Feng Zhang(King's College London), Hou-Feng Zheng(Jewish General Hospital), Neurodevelopmental disorders group(Royal Edinburgh Hospital), Richard Anney(King's College London), Muhammad Ayub(King's College London), Jeffrey C. Barrett(King's College London), Douglas Blackwood(Royal Edinburgh Hospital), Patrick F. Bolton(King's College London), Gerome Breen(King's College London), David Collier(Eli Lilly (United States)), Nick Craddock(Wellcome Sanger Institute), Lucy Crooks(Wellcome Sanger Institute), Sarah Curran(University of California, Los Angeles), David Curtis(University College London), Richard Durbin(Wellcome Sanger Institute), Louise Gallagher(St. James's Hospital), Daniel Geschwind(University of California, Los Angeles), Hugh Gurling(Wellcome Sanger Institute), Peter Holmans(King's College London), Irene Lee(Royal Edinburgh Hospital), Jouko Lönnqvist(Royal Edinburgh Hospital), Shane McCarthy(Wellcome Sanger Institute), Peter McGuffin(King's College London), Andrew M. McIntosh(Royal Edinburgh Hospital), Andrew G. McKechanie(Royal Edinburgh Hospital), Andrew McQuillin(University College London), James Morris(Broad Institute), Dawn Muddyman(Wellcome Sanger Institute), Michael O‘Donovan(Finnish Institute for Health and Welfare), Michael J. Owen(University of Helsinki), Aarno Palotie(Broad Institute), Jeremy Parr(University College London), Tiina Paunio(University of Helsinki), Olli Pietiläinen(University of Helsinki), Karola Rehnström(Wellcome Sanger Institute), Sally I. Sharp(University College London), David Skuse(University College London), David St Clair(University of Aberdeen), Jaana Suvisaari(University of Cambridge), James Walters(University of Cambridge), Hywel Williams(University College London), Obesity group(Wellcome Sanger Institute), Inês Barroso(University of Cambridge), Elena G. Bochukova(University of Cambridge), Rebecca Bounds(University of Cambridge), Anna F. Dominiczak(Wellcome Sanger Institute), Richard Durbin(Wellcome Sanger Institute), I. Sadaf Farooqi(University of Cambridge), Audrey E. Hendricks(Wellcome Sanger Institute), Julia M. Keogh(University of Cambridge), Gaëlle Marenne(Western General Hospital), Shane McCarthy(Wellcome Sanger Institute), Andrew D. Morris(Wellcome Sanger Institute), Dawn Muddyman(Wellcome Sanger Institute), Stephen O’Rahilly(University of Cambridge), David J. Porteous(Western General Hospital), Blair H. Smith(Wellcome Sanger Institute), Ioanna Tachmazidou(Wellcome Sanger Institute), Eleanor Wheeler(University of Cambridge), Eleftheria Zeggini(Wellcome Sanger Institute), Rare disease group(Centre for Human Genetics), Saeed Al Turki(Centre for Human Genetics), Carl A. Anderson(Great Ormond Street Hospital), Dinu Antony(Wellcome Sanger Institute), Inês Barroso(University of Cambridge), Phil Beales(Great Ormond Street Hospital), Jamie Bentham(Centre for Human Genetics), Shoumo Bhattacharya(Centre for Human Genetics), Mattia Calissano(Great Ormond Street Hospital), Keren Carss(Queen Mary University of London), Krishna Chatterjee(University of Cambridge), Sebahattin Çırak(Great Ormond Street Hospital), Catherine Cosgrove(Centre for Human Genetics), Richard Durbin(Wellcome Sanger Institute), David Fitzpatrick(Western General Hospital), James Floyd(Queen Mary University of London), A. Reghan Foley(Great Ormond Street Hospital), Christopher S. Franklin(Wellcome Sanger Institute), Marta Futema(Wellcome Sanger Institute), Detelina Grozeva(Great Ormond Street Hospital), Steve E. Humphries(University of Cambridge), Matthew E. Hurles(Guy's Hospital), Shane McCarthy(University of Cambridge), Hannah M. Mitchison(Wellcome Sanger Institute), Dawn Muddyman(Wellcome Sanger Institute), Francesco Muntoni(Great Ormond Street Hospital), Stephen O’Rahilly(University of Cambridge), Alexandros Onoufriadis(Guy's Hospital), Victoria Parker(University of Cambridge), Felicity Payne(Wellcome Sanger Institute), Vincent Plagnol(University of Cambridge), F. Lucy Raymond(University of Cambridge), Nicola D. Roberts(Wellcome Sanger Institute), David B. Savage(University of Cambridge), Peter Scambler(Great Ormond Street Hospital), Miriam Schmidts(Radboud University Nijmegen), Nadia Schoenmakers(University of Cambridge), Robert K. Semple(University of Cambridge), Eva Serra(Western General Hospital), Olivera Spasić-Bošković(Addenbrooke's Hospital), Elizabeth Stevens(Great Ormond Street Hospital), Margriet van Kogelenberg(Wellcome Sanger Institute), Parthiban Vijayarangakannan(Wellcome Sanger Institute), Klaudia Walter(Wellcome Sanger Institute), Kathleen A. Williamson(BGI Group (China)), Crispian Wilson(King's College London), Tamieka Whyte(Université du Québec à Montréal), Statistics group(Wellcome Sanger Institute), Antonio Ciampi(Jewish General Hospital), Celia M. T. Greenwood(Jewish General Hospital), Audrey E. Hendricks(Wellcome Sanger Institute), Rui Li(King's College London), Sarah Metrustry(King's College London), Karim Oualkacha(Université du Québec à Montréal), Ioanna Tachmazidou(Wellcome Sanger Institute), Changjiang Xu(Jewish General Hospital), Eleftheria Zeggini(Wellcome Sanger Institute), Ethics group(National Cancer Research Institute), Martin Bobrow(Genetic Alliance UK (United Kingdom)), Patrick F. Bolton(King's College London), Richard Durbin(Great Ormond Street Hospital), David R. Fitzpatrick(Western General Hospital), Heather Griffin(University of Cambridge), Matthew E. Hurles(Wellcome Sanger Institute), Jane Kaye(King's College London), Karen L. Kennedy(Wellcome Sanger Institute), Alastair Kent(St James's University Hospital), Dawn Muddyman(Wellcome Sanger Institute), Francesco Muntoni(Great Ormond Street Hospital), F. Lucy Raymond(Addenbrooke's Hospital), Robert K. Semple(St George's, University of London), Carol Smee(University of Lisbon), Timothy D. Spector(King's College London), Nicholas J. Timpson(Northwick Park Hospital), Incidental findings group(University College London), Ruth Charlton(St James's University Hospital), Rosemary Ekong(University College London), Marta Futema(Guy's Hospital), Steve E. Humphries(St James's University Hospital), Farrah Khawaja(St George's, University of London), Luís R. Lopes(University of Lisbon), Nicola Migone(University College London), Stewart J. Payne(St George's, University of London), Vincent Plagnol(University College London), Rebecca C. Pollitt(Wellcome Sanger Institute), Sue Povey(University of Cambridge), Cheryl K. Ridout(Guy's Hospital), Rachel L. Robinson(St James's University Hospital), Richard H. Scott(University of Cambridge), Adam Shaw(Guy's and St Thomas' NHS Foundation Trust), Petros Syrris(Wellcome Sanger Institute), Rohan Taylor(St George's, University of London), Anthony M. Vandersteen(National Cancer Research Institute), Jeffrey C. Barrett(Wellcome Sanger Institute), Inês Barroso(University of Cambridge), George Davey Smith(Wellcome Sanger Institute), Richard Durbin(Wellcome Sanger Institute), I. Sadaf Farooqi(Broad Institute), David R. Fitzpatrick(King's College London), Matthew E. Hurles(University of Cambridge), Jane Kaye(King's College London), Karen L. Kennedy(Wellcome Sanger Institute), Cordelia Langford(Wellcome Sanger Institute), Shane McCarthy(Wellcome Sanger Institute), Dawn Muddyman(University of London), Michael J. Owen(University of London), Aarno Palotie(Broad Institute), J. Brent Richards(University of Trieste), Nicole Soranzo(University of Cambridge), Timothy D. Spector(King's College London), Jim Stalker(Qatar Airways (Qatar)), Nicholas J. Timpson(University of Bristol), Eleftheria Zeggini(Wellcome Sanger Institute), Lipid meta-analysis group(European Bioinformatics Institute), Antoinette Amuzu(University of London), Juan P. Casas(University of London), John C. Chambers(Heidelberg University), Massimiliano Cocca(University of Trieste), George Dedoussis(University of Cambridge), Giovanni Gambaro(University of Cambridge), Paolo Gasparini(University of Verona), Tom R. Gaunt(Medical University of Graz), Jie Huang(Wellcome Sanger Institute), Valentina Iotchkova(European Bioinformatics Institute), Aaron Isaacs(Erasmus MC), Jon Johnson(University of Copenhagen), Marcus E. Kleber(University of Copenhagen), Jaspal S. Kooner(University of Bristol), Claudia Langenberg(University of Cambridge), Jian’an Luan(University of Cambridge), Giovanni Malerba(University of Verona), Winfried März(Medical University of Graz), Angela Matchan(Wellcome Sanger Institute), Josine L. Min(San Raffaele University of Rome), Richard Morris(Copenhagen University Hospital), Børge G. Nordestgaard(University of Copenhagen), Marianne Benn(University of Copenhagen), Susan Ring(University of Copenhagen), Robert A. Scott(St George's, University of London), Nicole Soranzo(University of Verona), Lorraine Southam(Centre for Human Genetics), Nicholas J. Timpson(University of Bristol), Daniela Toniolo(San Raffaele University of Rome), Michela Traglia(San Raffaele University of Rome), Anne Tybjærg‐Hansen(University of Copenhagen), Cornelia M. van Duijn(Erasmus MC), Elisabeth M. van Leeuwen(Erasmus MC), Anette Varbo(University of Copenhagen), Peter H. Whincup(St George's, University of London), Gianluigi Zaza(University of Verona), Eleftheria Zeggini(Wellcome Sanger Institute), Weihua Zhang(St Mary's Hospital)
Nature
September 14, 2015
Cited by 1,187Open Access
Full Text

Abstract

The contribution of rare and low-frequency variants to human traits is largely unexplored. Here we describe insights from sequencing whole genomes (low read depth, 7×) or exomes (high read depth, 80×) of nearly 10,000 individuals from population-based and disease collections. In extensively phenotyped cohorts we characterize over 24 million novel sequence variants, generate a highly accurate imputation reference panel and identify novel alleles associated with levels of triglycerides (APOB), adiponectin (ADIPOQ) and low-density lipoprotein cholesterol (LDLR and RGAG1) from single-marker and rare variant aggregation tests. We describe population structure and functional annotation of rare and low-frequency variants, use the data to estimate the benefits of sequencing for association studies, and summarize lessons from disease-specific collections. Finally, we make available an extensive resource, including individual-level genetic and phenotypic data and web-based tools to facilitate the exploration of association results. Low read depth sequencing of whole genomes and high read depth exomes of nearly 10,000 extensively phenotyped individuals are combined to help characterize novel sequence variants, generate a highly accurate imputation reference panel and identify novel alleles associated with lipid-related traits; in addition to describing population structure and providing functional annotation of rare and low-frequency variants the authors use the data to estimate the benefits of sequencing for association studies. This paper, combining data and initial findings from the different arms of the UK10K project, describes insights from low-read-depth sequencing of whole genomes or high-read-depth exome sequencing of nearly 10,000 individuals sampled from a range of disease collections, as well as participants from healthy population based cohorts. The authors characterize novel sequence variants, generate a highly accurate imputation reference panel and identify novel alleles associated with lipid-related traits. In addition to describing population structure and providing functional annotation of rare and low frequency variants, they use the data to estimate the benefits of sequencing for association studies.


Related Papers

No related papers found

Powered by citation graph analysis